MedPath

melatonin in dialysis patients

Phase 2
Conditions
The effect of melatonin on CRP and lipid profiles of dialysis patients.
Registration Number
IRCT20200308046724N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
28
Inclusion Criteria

Patients aged 18 years and over and
who had been undergoing hemodialysis for at least 3 months
had triglycerides =150 mg / dl, low HDL< 40 mg / dl in men and <50 mg / dl in women)
and CRP> 5

Exclusion Criteria

Patients with a history of stroke and myocardial infarction and Transient Ischemic Attack (TIA),, , , and
peripheral vascular disease
malignancy,
liver cirrhosis
COPD
active hepatitis
heart failure
autoimmune diseases
corticosteroid use
non-steroidal anti-inflammatory drugs (NSAIDs)andstatin
positive viral marker
hepatitis
HIV
had a history of hospitalization and infection during the last month

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
CRP &LIPIDPROFILE. Timepoint: CRP and lipid profile tests were performed at the beginning of the course and at the end of 3 months. Method of measurement: blood test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath